Loading...

REMSleep Holdings, Inc.

RMSLPNK
Healthcare
Medical - Devices
$0.004
$-0.00(-17.71%)

REMSleep Holdings, Inc. (RMSL) Financial Performance & Income Statement Overview

View comprehensive annual and quarterly summaries for REMSleep Holdings, Inc. (RMSL), featuring income statements, balance sheets, and cash flow data.

Revenue Growth
-42.48%
42.48%
Operating Income Growth
55.21%
55.21%
Net Income Growth
39.36%
39.36%
Operating Cash Flow Growth
13.68%
13.68%
Operating Margin
-1741.75%
1741.75%
Gross Margin
-132.81%
132.81%
Net Profit Margin
-2663.49%
2663.49%
ROE
-285.88%
285.88%
ROIC
-406.82%
406.82%

REMSleep Holdings, Inc. (RMSL) Income Statement & Financial Overview

Analyze REMSleep Holdings, Inc.’s RMSL earnings with segmented quarterly and yearly financial statement figures.

MetricQ1 2025Q4 2024Q3 2024Q2 2024
Revenue$0.00-$5550.00$37260.00$27594.00
Cost of Revenue$0.00$21057.00$58560.00$5940.00
Gross Profit$0.00-$26607.00-$21300.00$21654.00
Gross Profit Ratio$0.00$4.79-$0.57$0.78
R&D Expenses$17200.00-$9350.00$40775.00$132020.00
SG&A Expenses$114115.00$161096.00$132040.00$186499.00
Operating Expenses$131315.00$151746.00$172815.00$318519.00
Total Costs & Expenses$131315.00$172803.00$231375.00$324459.00
Interest Income$0.00$0.00$0.00$0.00
Interest Expense$76332.00$17843.00$64392.00$32932.00
Depreciation & Amortization$4836.00$10385.00$9804.00$26084.00
EBITDA-$4320.00-$294000.00-$203710.00-$167000.00
EBITDA Ratio$0.00$52.97-$5.47-$6.05
Operating Income-$131315.00-$178348.00-$194115.00-$297000.00
Operating Income Ratio$0.00$32.13-$5.21-$10.76
Other Income/Expenses (Net)$45827.00-$144000.00-$83794.00$71266.00
Income Before Tax-$85488.00-$322000.00-$277909.00-$226000.00
Income Before Tax Ratio$0.00$58.02-$7.46-$8.19
Income Tax Expense$0.00$0.00$0.00$0.00
Net Income-$85488.00-$321909.00-$277909.00-$226000.00
Net Income Ratio$0.00$58.002-$7.46-$8.19
EPS-$0.00-$0.00-$0.00-$0.00
Diluted EPS-$0.00-$0.00-$0.00-$0.00
Weighted Avg Shares Outstanding$1.53B$1.48B$1.51B$1.47B
Weighted Avg Shares Outstanding (Diluted)$1.53B$1.48B$1.51B$1.47B

Over the last four quarters, REMSleep Holdings, Inc. achieved steady financial progress, growing revenue from $27594.00 in Q2 2024 to $0.00 in Q1 2025. Gross profit stayed firm with margins at N/A in Q1 2025 versus 78% in Q2 2024. Operating income totaled -$131315.00 in Q1 2025, maintaining a N/A margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at -$4320.00. Net income rose to -$85488.00, with EPS at -$0.00. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;